European and US experts disagree on thyroid eye disease treatment
28 Oct 2021
In the US teprotumumab is the most common therapy for thyroid eye, whilst Europeans favour intravenous steroids, according to a survey conducted by the American Thyroid Association and the European Thyroid Association.
